25 XP   0   0   10

Chugai Pharmaceutical Co Ltd ADR
Buy, Hold or Sell?

Let's analyse Chugai Pharmaceutical Co Ltd ADR together

PenkeI guess you are interested in Chugai Pharmaceutical Co Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chugai Pharmaceutical Co Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chugai Pharmaceutical Co Ltd ADR

I send you an email if I find something interesting about Chugai Pharmaceutical Co Ltd ADR.

Quick analysis of Chugai Pharmaceutical Co Ltd ADR (30 sec.)










What can you expect buying and holding a share of Chugai Pharmaceutical Co Ltd ADR? (30 sec.)

How much money do you get?

How much money do you get?
$39.99
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$494.00
Expected worth in 1 year
$555.15
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$101.13
Return On Investment
621.2%

For what price can you sell your share?

Current Price per Share
$16.28
Expected price per share
$13.85 - $22.61
How sure are you?
50%

1. Valuation of Chugai Pharmaceutical Co Ltd ADR (5 min.)




Live pricePrice per Share (EOD)

$16.28

Intrinsic Value Per Share

$689.05 - $1,394.90

Total Value Per Share

$1,183.05 - $1,888.90

2. Growth of Chugai Pharmaceutical Co Ltd ADR (5 min.)




Is Chugai Pharmaceutical Co Ltd ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$1.6t$1.3t$207.4b13.6%

How much money is Chugai Pharmaceutical Co Ltd ADR making?

Current yearPrevious yearGrowGrow %
Making money$528.8m$608.4m-$79.5m-15.0%
Net Profit Margin29.5%30.2%--

How much money comes from the company's main activities?

3. Financial Health of Chugai Pharmaceutical Co Ltd ADR (5 min.)




What can you expect buying and holding a share of Chugai Pharmaceutical Co Ltd ADR? (5 min.)

Welcome investor! Chugai Pharmaceutical Co Ltd ADR's management wants to use your money to grow the business. In return you get a share of Chugai Pharmaceutical Co Ltd ADR.

What can you expect buying and holding a share of Chugai Pharmaceutical Co Ltd ADR?

First you should know what it really means to hold a share of Chugai Pharmaceutical Co Ltd ADR. And how you can make/lose money.

Speculation

The Price per Share of Chugai Pharmaceutical Co Ltd ADR is $16.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chugai Pharmaceutical Co Ltd ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chugai Pharmaceutical Co Ltd ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $494.00. Based on the TTM, the Book Value Change Per Share is $15.29 per quarter. Based on the YOY, the Book Value Change Per Share is $17.96 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $10.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chugai Pharmaceutical Co Ltd ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.181.1%0.161.0%0.181.1%0.140.8%0.080.5%
Usd Book Value Change Per Share27.60169.5%15.2993.9%17.96110.3%13.2081.1%8.0049.1%
Usd Dividend Per Share0.110.7%10.0061.4%10.5064.5%7.9148.6%5.0931.3%
Usd Total Gains Per Share27.71170.2%25.28155.3%28.46174.8%21.11129.7%13.0880.4%
Usd Price Per Share18.85-15.19-13.64-70.24-48.26-
Price to Earnings Ratio26.16-23.52-19.30-188.76-197.19-
Price-to-Total Gains Ratio0.68-0.60-0.51-4.88-8.51-
Price to Book Ratio0.04-0.03-0.03-0.26-0.20-
Price-to-Total Gains Ratio0.68-0.60-0.51-4.88-8.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.28
Number of shares61
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share10.007.91
Usd Book Value Change Per Share15.2913.20
Usd Total Gains Per Share25.2821.11
Gains per Quarter (61 shares)1,542.291,287.73
Gains per Year (61 shares)6,169.155,150.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1243937306159192932225141
248787460123283858644410292
3731811190184975787966615443
49757149202466677161288820594
512196186503083596451611025745
6146352238037004115741933230896
7170742611043173135032255436047
8195142984049342154312577641198
9219533356955511173602899846349
10243923729961680192893222051500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.03.00.092.5%53.07.00.088.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%

Fundamentals of Chugai Pharmaceutical Co Ltd ADR

About Chugai Pharmaceutical Co Ltd ADR

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Fundamental data was last updated by Penke on 2024-03-30 07:02:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Chugai Pharmaceutical Co Ltd ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chugai Pharmaceutical Co Ltd ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 33.3% means that $0.33 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 33.3%. The company is making a huge profit. +2
  • The TTM is 29.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.3%TTM29.5%+3.8%
TTM29.5%YOY30.2%-0.7%
TTM29.5%5Y28.0%+1.5%
5Y28.0%10Y20.4%+7.6%
1.1.2. Return on Assets

Shows how efficient Chugai Pharmaceutical Co Ltd ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • 0.0% Return on Assets means that Chugai Pharmaceutical Co Ltd ADR generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%+0.0%
TTM0.0%YOY0.0%0.0%
TTM0.0%5Y0.0%0.0%
5Y0.0%10Y0.0%+0.0%
1.1.3. Return on Equity

Shows how efficient Chugai Pharmaceutical Co Ltd ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • 0.0% Return on Equity means Chugai Pharmaceutical Co Ltd ADR generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM0.0%+0.0%
TTM0.0%YOY0.0%0.0%
TTM0.0%5Y0.0%0.0%
5Y0.0%10Y0.0%+0.0%

1.2. Operating Efficiency of Chugai Pharmaceutical Co Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chugai Pharmaceutical Co Ltd ADR is operating .

  • Measures how much profit Chugai Pharmaceutical Co Ltd ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 44.3% means the company generated $0.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 44.3%. The company is operating very efficient. +2
  • The TTM is 39.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ44.3%TTM39.8%+4.5%
TTM39.8%YOY42.8%-3.0%
TTM39.8%5Y38.7%+1.2%
5Y38.7%10Y27.9%+10.8%
1.2.2. Operating Ratio

Measures how efficient Chugai Pharmaceutical Co Ltd ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.49 means that the operating costs are $0.49 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 0.495. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.586. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.586-0.091
TTM0.586YOY0.572+0.015
TTM0.5865Y0.610-0.024
5Y0.61010Y0.716-0.106

1.3. Liquidity of Chugai Pharmaceutical Co Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chugai Pharmaceutical Co Ltd ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 4.74 means the company has $4.74 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 4.741. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.414. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.741TTM4.414+0.326
TTM4.414YOY3.399+1.015
TTM4.4145Y3.999+0.415
5Y3.99910Y4.460-0.461
1.3.2. Quick Ratio

Measures if Chugai Pharmaceutical Co Ltd ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 4.65 means the company can pay off $4.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 4.648. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.348. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.648TTM4.348+0.300
TTM4.348YOY3.233+1.115
TTM4.3485Y3.767+0.581
5Y3.76710Y4.068-0.302

1.4. Solvency of Chugai Pharmaceutical Co Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chugai Pharmaceutical Co Ltd ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.16 means that Chugai Pharmaceutical Co Ltd ADR assets are financed with 15.9% credit (debt) and the remaining percentage (100% - 15.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 0.159. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.169. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.159TTM0.169-0.010
TTM0.169YOY0.220-0.051
TTM0.1695Y0.191-0.021
5Y0.19110Y0.186+0.005
1.4.2. Debt to Equity Ratio

Measures if Chugai Pharmaceutical Co Ltd ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 18.9% means that company has $0.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The MRQ is 0.189. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.204. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.189TTM0.204-0.015
TTM0.204YOY0.283-0.079
TTM0.2045Y0.237-0.032
5Y0.23710Y0.229+0.007

2. Market Valuation of Chugai Pharmaceutical Co Ltd ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Chugai Pharmaceutical Co Ltd ADR generates.

  • Above 15 is considered overpriced but always compare Chugai Pharmaceutical Co Ltd ADR to the Drug Manufacturers - General industry mean.
  • A PE ratio of 26.16 means the investor is paying $26.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The EOD is 22.591. Based on the earnings, the company is fair priced.
  • The MRQ is 26.157. Based on the earnings, the company is overpriced. -1
  • The TTM is 23.520. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD22.591MRQ26.157-3.566
MRQ26.157TTM23.520+2.637
TTM23.520YOY19.301+4.220
TTM23.5205Y188.759-165.239
5Y188.75910Y197.187-8.427
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The EOD is 0.126. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.146. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.233. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.126MRQ0.146-0.020
MRQ0.146TTM0.233-0.087
TTM0.233YOY0.203+0.031
TTM0.2335Y0.365-0.132
5Y0.36510Y0.342+0.023
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chugai Pharmaceutical Co Ltd ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.04 means the investor is paying $0.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Chugai Pharmaceutical Co Ltd ADR:

  • The EOD is 0.033. Based on the equity, the company is cheap. +2
  • The MRQ is 0.038. Based on the equity, the company is cheap. +2
  • The TTM is 0.033. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.033MRQ0.038-0.005
MRQ0.038TTM0.033+0.006
TTM0.033YOY0.034-0.002
TTM0.0335Y0.261-0.228
5Y0.26110Y0.197+0.064
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Chugai Pharmaceutical Co Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--27.59515.287+81%17.956+54%13.205+109%7.995+245%
Book Value Per Share--494.003464.230+6%401.202+23%343.242+44%269.964+83%
Current Ratio--4.7414.414+7%3.399+39%3.999+19%4.460+6%
Debt To Asset Ratio--0.1590.169-6%0.220-28%0.191-17%0.186-15%
Debt To Equity Ratio--0.1890.204-7%0.283-33%0.237-20%0.229-18%
Dividend Per Share--0.1129.997-99%10.501-99%7.905-99%5.090-98%
Eps--0.1800.161+12%0.185-3%0.136+33%0.083+116%
Free Cash Flow Per Share--32.31825.528+27%13.134+146%15.266+112%8.867+264%
Free Cash Flow To Equity Per Share--31.64314.949+112%2.069+1430%6.778+367%3.477+810%
Gross Profit Margin--1.0000.740+35%0.779+28%0.684+46%0.246+306%
Intrinsic Value_10Y_max--1394.897--------
Intrinsic Value_10Y_min--689.045--------
Intrinsic Value_1Y_max--82.347--------
Intrinsic Value_1Y_min--41.436--------
Intrinsic Value_3Y_max--291.188--------
Intrinsic Value_3Y_min--149.151--------
Intrinsic Value_5Y_max--552.801--------
Intrinsic Value_5Y_min--283.058--------
Market Cap53571454576.640-16%62028373388.80049987669543.690+24%44868030081.270+38%231118807076.786-73%158795812294.297-61%
Net Profit Margin--0.3330.295+13%0.302+10%0.280+19%0.204+63%
Operating Margin--0.4430.398+11%0.428+3%0.387+15%0.279+59%
Operating Ratio--0.4950.586-16%0.572-13%0.610-19%0.716-31%
Pb Ratio0.033-16%0.0380.033+17%0.034+12%0.261-85%0.197-81%
Pe Ratio22.591-16%26.15723.520+11%19.301+36%188.759-86%197.187-87%
Price Per Share16.280-16%18.85015.190+24%13.635+38%70.235-73%48.257-61%
Price To Free Cash Flow Ratio0.126-16%0.1460.233-37%0.203-28%0.365-60%0.342-57%
Price To Total Gains Ratio0.588-16%0.6800.598+14%0.514+32%4.878-86%8.513-92%
Quick Ratio--4.6484.348+7%3.233+44%3.767+23%4.068+14%
Return On Assets--0.0000.000+7%0.000-15%0.000-3%0.000+36%
Return On Equity--0.0000.000+5%0.000-21%0.000-7%0.000+31%
Total Gains Per Share--27.70725.283+10%28.457-3%21.110+31%13.085+112%
Usd Book Value--1625580000000.0001527704750000.000+6%1320215750000.000+23%1129504800000.000+44%888364550000.000+83%
Usd Book Value Change Per Share--27.59515.287+81%17.956+54%13.205+109%7.995+245%
Usd Book Value Per Share--494.003464.230+6%401.202+23%343.242+44%269.964+83%
Usd Dividend Per Share--0.1129.997-99%10.501-99%7.905-99%5.090-98%
Usd Eps--0.1800.161+12%0.185-3%0.136+33%0.083+116%
Usd Free Cash Flow--106346000000.00084005250000.000+27%43218250000.000+146%50237100000.000+112%29178225000.000+264%
Usd Free Cash Flow Per Share--32.31825.528+27%13.134+146%15.266+112%8.867+264%
Usd Free Cash Flow To Equity Per Share--31.64314.949+112%2.069+1430%6.778+367%3.477+810%
Usd Market Cap53571454576.640-16%62028373388.80049987669543.690+24%44868030081.270+38%231118807076.786-73%158795812294.297-61%
Usd Price Per Share16.280-16%18.85015.190+24%13.635+38%70.235-73%48.257-61%
Usd Profit--592839000.000528892000.000+12%608447125.000-3%446937075.000+33%277239625.000+114%
Usd Revenue--1779778000.0001805969750.000-1%2047413875.000-13%1574365650.000+13%1204111512.500+48%
Usd Total Gains Per Share--27.70725.283+10%28.457-3%21.110+31%13.085+112%
 EOD+4 -4MRQTTM+30 -6YOY+23 -135Y+28 -810Y+30 -6

3.2. Fundamental Score

Let's check the fundamental score of Chugai Pharmaceutical Co Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.591
Price to Book Ratio (EOD)Between0-10.033
Net Profit Margin (MRQ)Greater than00.333
Operating Margin (MRQ)Greater than00.443
Quick Ratio (MRQ)Greater than14.648
Current Ratio (MRQ)Greater than14.741
Debt to Asset Ratio (MRQ)Less than10.159
Debt to Equity Ratio (MRQ)Less than10.189
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Chugai Pharmaceutical Co Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.977
Ma 20Greater thanMa 5017.978
Ma 50Greater thanMa 10019.153
Ma 100Greater thanMa 20018.816
OpenGreater thanClose15.940
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,932,547,000
Total Liabilities306,967,000
Total Stockholder Equity1,625,580,000
 As reported
Total Liabilities 306,967,000
Total Stockholder Equity+ 1,625,580,000
Total Assets = 1,932,547,000

Assets

Total Assets1,932,547,000
Total Current Assets1,366,426,000
Long-term Assets566,121,000
Total Current Assets
Cash And Cash Equivalents 458,674,000
Short-term Investments 280,308,000
Net Receivables 320,348,000
Inventory 273,480,000
Other Current Assets 33,616,000
Total Current Assets  (as reported)1,366,426,000
Total Current Assets  (calculated)1,366,426,000
+/-0
Long-term Assets
Property Plant Equipment 420,701,000
Intangible Assets 19,860,000
Long-term Assets Other 61,086,000
Long-term Assets  (as reported)566,121,000
Long-term Assets  (calculated)501,647,000
+/- 64,474,000

Liabilities & Shareholders' Equity

Total Current Liabilities288,217,000
Long-term Liabilities18,750,000
Total Stockholder Equity1,625,580,000
Total Current Liabilities
Accounts payable 112,468,000
Other Current Liabilities 175,749,000
Total Current Liabilities  (as reported)288,217,000
Total Current Liabilities  (calculated)288,217,000
+/-0
Long-term Liabilities
Long-term Liabilities Other 7,224,000
Long-term Liabilities  (as reported)18,750,000
Long-term Liabilities  (calculated)7,224,000
+/- 11,526,000
Total Stockholder Equity
Common Stock73,202,000
Retained Earnings 1,488,738,000
Accumulated Other Comprehensive Income -5,715,000
Other Stockholders Equity 69,355,000
Total Stockholder Equity (as reported)1,625,580,000
Total Stockholder Equity (calculated)1,625,580,000
+/-0
Other
Cash and Short Term Investments 738,982,000
Common Stock Shares Outstanding 1,645,318
Liabilities and Stockholders Equity 1,932,547,000
Net Debt -458,674,000
Net Invested Capital 1,625,580,000
Net Working Capital 1,078,209,000
Property Plant and Equipment Gross 420,701,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
478,746,000
501,749,000
505,306,000
540,549,000
511,136,000
507,164,000
501,175,000
508,016,000
520,272,000
529,359,000
534,420,000
533,482,000
532,473,000
542,152,000
544,103,000
587,718,000
632,221,000
654,495,000
671,612,000
697,212,000
701,565,000
708,156,000
713,928,000
739,538,000
727,259,000
744,315,000
753,492,000
787,401,000
762,429,000
766,881,000
769,863,000
806,285,000
798,237,000
821,699,000
817,945,000
852,473,000
852,886,000
873,347,000
890,843,000
919,548,000
932,242,000
986,620,000
1,025,336,000
1,058,915,000
1,045,605,000
1,072,144,000
1,136,108,000
1,235,498,000
1,144,627,000
1,275,767,000
1,353,363,000
1,538,694,000
1,584,948,000
1,625,604,000
1,700,818,000
1,869,758,000
1,771,973,000
1,831,590,000
1,817,649,000
1,932,547,000
1,932,547,0001,817,649,0001,831,590,0001,771,973,0001,869,758,0001,700,818,0001,625,604,0001,584,948,0001,538,694,0001,353,363,0001,275,767,0001,144,627,0001,235,498,0001,136,108,0001,072,144,0001,045,605,0001,058,915,0001,025,336,000986,620,000932,242,000919,548,000890,843,000873,347,000852,886,000852,473,000817,945,000821,699,000798,237,000806,285,000769,863,000766,881,000762,429,000787,401,000753,492,000744,315,000727,259,000739,538,000713,928,000708,156,000701,565,000697,212,000671,612,000654,495,000632,221,000587,718,000544,103,000542,152,000532,473,000533,482,000534,420,000529,359,000520,272,000508,016,000501,175,000507,164,000511,136,000540,549,000505,306,000501,749,000478,746,000
   > Total Current Assets 
347,856,000
372,910,000
377,738,000
411,302,000
383,897,000
383,389,000
379,092,000
386,537,000
402,501,000
412,104,000
417,725,000
419,429,000
421,085,000
430,812,000
433,001,000
475,695,000
439,673,000
463,703,000
478,712,000
504,235,000
508,965,000
515,407,000
518,740,000
538,904,000
526,383,000
543,380,000
548,574,000
567,773,000
536,803,000
539,916,000
542,889,000
578,760,000
562,184,000
578,455,000
571,652,000
599,141,000
604,260,000
622,924,000
620,971,000
600,093,000
598,889,000
634,246,000
668,039,000
699,680,000
663,251,000
695,612,000
742,331,000
834,906,000
740,971,000
857,123,000
913,595,000
1,063,661,000
1,091,648,000
1,126,523,000
1,184,567,000
1,336,537,000
1,226,987,000
1,272,821,000
1,256,979,000
1,366,426,000
1,366,426,0001,256,979,0001,272,821,0001,226,987,0001,336,537,0001,184,567,0001,126,523,0001,091,648,0001,063,661,000913,595,000857,123,000740,971,000834,906,000742,331,000695,612,000663,251,000699,680,000668,039,000634,246,000598,889,000600,093,000620,971,000622,924,000604,260,000599,141,000571,652,000578,455,000562,184,000578,760,000542,889,000539,916,000536,803,000567,773,000548,574,000543,380,000526,383,000538,904,000518,740,000515,407,000508,965,000504,235,000478,712,000463,703,000439,673,000475,695,000433,001,000430,812,000421,085,000419,429,000417,725,000412,104,000402,501,000386,537,000379,092,000383,389,000383,897,000411,302,000377,738,000372,910,000347,856,000
       Cash And Cash Equivalents 
77,584,000
90,833,000
77,622,000
106,978,000
101,135,000
81,270,000
70,177,000
76,212,000
101,719,000
109,226,000
110,672,000
107,163,000
123,107,000
129,971,000
97,116,000
110,935,000
100,553,000
100,461,000
112,357,000
115,070,000
115,009,000
128,765,000
108,142,000
114,037,000
123,618,000
126,612,000
121,552,000
101,707,000
106,778,000
100,102,000
100,048,000
95,368,000
103,658,000
110,693,000
97,582,000
139,074,000
152,819,000
154,599,000
145,977,000
146,860,000
125,818,000
149,165,000
177,022,000
203,941,000
138,710,000
196,603,000
182,711,000
212,333,000
162,049,000
187,131,000
192,518,000
267,753,000
230,474,000
360,311,000
274,043,000
222,169,000
247,686,000
365,016,000
331,341,000
458,674,000
458,674,000331,341,000365,016,000247,686,000222,169,000274,043,000360,311,000230,474,000267,753,000192,518,000187,131,000162,049,000212,333,000182,711,000196,603,000138,710,000203,941,000177,022,000149,165,000125,818,000146,860,000145,977,000154,599,000152,819,000139,074,00097,582,000110,693,000103,658,00095,368,000100,048,000100,102,000106,778,000101,707,000121,552,000126,612,000123,618,000114,037,000108,142,000128,765,000115,009,000115,070,000112,357,000100,461,000100,553,000110,935,00097,116,000129,971,000123,107,000107,163,000110,672,000109,226,000101,719,00076,212,00070,177,00081,270,000101,135,000106,978,00077,622,00090,833,00077,584,000
       Short-term Investments 
46,034,000
54,492,000
55,606,000
52,157,000
55,693,000
61,690,000
58,701,000
59,699,000
57,999,000
58,994,000
58,999,000
60,995,000
66,993,000
70,992,000
100,998,000
100,993,000
111,309,000
122,946,000
112,523,000
119,573,000
115,511,000
115,055,000
114,925,000
116,030,000
114,344,000
120,033,000
121,714,000
134,419,000
112,895,000
109,353,000
109,219,000
110,176,000
108,393,000
110,208,000
110,879,000
104,018,000
113,803,000
119,872,000
122,876,000
102,533,000
111,533,000
111,860,000
109,134,000
129,117,000
134,009,000
94,090,000
136,128,000
166,287,000
181,317,000
204,097,000
204,131,000
204,217,000
201,348,000
231,930,000
271,252,000
280,938,000
306,928,000
299,967,000
287,424,000
280,308,000
280,308,000287,424,000299,967,000306,928,000280,938,000271,252,000231,930,000201,348,000204,217,000204,131,000204,097,000181,317,000166,287,000136,128,00094,090,000134,009,000129,117,000109,134,000111,860,000111,533,000102,533,000122,876,000119,872,000113,803,000104,018,000110,879,000110,208,000108,393,000110,176,000109,219,000109,353,000112,895,000134,419,000121,714,000120,033,000114,344,000116,030,000114,925,000115,055,000115,511,000119,573,000112,523,000122,946,000111,309,000100,993,000100,998,00070,992,00066,993,00060,995,00058,999,00058,994,00057,999,00059,699,00058,701,00061,690,00055,693,00052,157,00055,606,00054,492,00046,034,000
       Net Receivables 
134,119,000
123,886,000
143,224,000
142,665,000
109,055,000
119,667,000
121,528,000
133,317,000
117,727,000
124,339,000
120,498,000
133,655,000
116,613,000
120,083,000
121,825,000
140,208,000
105,649,000
120,001,000
117,357,000
128,387,000
136,525,000
118,133,000
134,277,000
159,887,000
130,853,000
139,637,000
138,534,000
158,717,000
134,621,000
139,651,000
131,810,000
167,483,000
141,037,000
149,808,000
169,191,000
175,001,000
154,084,000
162,834,000
172,037,000
179,559,000
175,874,000
189,828,000
197,506,000
181,641,000
195,046,000
213,693,000
224,319,000
253,354,000
190,709,000
243,224,000
293,356,000
356,009,000
391,298,000
268,897,000
275,424,000
514,283,000
362,542,000
296,993,000
317,166,000
320,348,000
320,348,000317,166,000296,993,000362,542,000514,283,000275,424,000268,897,000391,298,000356,009,000293,356,000243,224,000190,709,000253,354,000224,319,000213,693,000195,046,000181,641,000197,506,000189,828,000175,874,000179,559,000172,037,000162,834,000154,084,000175,001,000169,191,000149,808,000141,037,000167,483,000131,810,000139,651,000134,621,000158,717,000138,534,000139,637,000130,853,000159,887,000134,277,000118,133,000136,525,000128,387,000117,357,000120,001,000105,649,000140,208,000121,825,000120,083,000116,613,000133,655,000120,498,000124,339,000117,727,000133,317,000121,528,000119,667,000109,055,000142,665,000143,224,000123,886,000134,119,000
       Inventory 
78,667,000
93,991,000
90,403,000
92,641,000
99,963,000
111,706,000
115,906,000
104,884,000
108,511,000
110,440,000
115,732,000
104,983,000
101,246,000
99,419,000
101,273,000
108,893,000
116,154,000
114,092,000
128,571,000
128,536,000
129,475,000
141,771,000
150,971,000
139,571,000
147,755,000
145,915,000
154,301,000
161,135,000
167,305,000
173,532,000
187,115,000
185,440,000
189,460,000
188,256,000
177,742,000
169,056,000
168,097,000
169,999,000
163,841,000
159,360,000
168,728,000
167,692,000
168,956,000
168,122,000
174,355,000
172,050,000
179,575,000
183,893,000
184,659,000
199,163,000
201,421,000
208,838,000
225,480,000
218,465,000
313,015,000
292,206,000
278,859,000
266,405,000
277,463,000
273,480,000
273,480,000277,463,000266,405,000278,859,000292,206,000313,015,000218,465,000225,480,000208,838,000201,421,000199,163,000184,659,000183,893,000179,575,000172,050,000174,355,000168,122,000168,956,000167,692,000168,728,000159,360,000163,841,000169,999,000168,097,000169,056,000177,742,000188,256,000189,460,000185,440,000187,115,000173,532,000167,305,000161,135,000154,301,000145,915,000147,755,000139,571,000150,971,000141,771,000129,475,000128,536,000128,571,000114,092,000116,154,000108,893,000101,273,00099,419,000101,246,000104,983,000115,732,000110,440,000108,511,000104,884,000115,906,000111,706,00099,963,00092,641,00090,403,00093,991,00078,667,000
       Other Current Assets 
11,452,000
9,708,000
10,883,000
16,861,000
18,051,000
9,056,000
12,780,000
12,425,000
16,545,000
9,105,000
11,824,000
12,633,000
13,126,000
10,347,000
11,789,000
14,666,000
6,008,000
6,203,000
7,904,000
12,669,000
12,445,000
11,683,000
10,425,000
9,379,000
9,813,000
11,183,000
12,473,000
11,795,000
15,204,000
17,278,000
14,697,000
20,293,000
19,636,000
19,490,000
16,258,000
11,992,000
15,457,000
15,620,000
16,240,000
11,781,000
16,936,000
15,701,000
15,421,000
16,859,000
21,131,000
19,176,000
19,598,000
19,039,000
22,237,000
23,508,000
22,169,000
26,844,000
43,048,000
46,920,000
50,833,000
26,941,000
30,972,000
44,440,000
43,585,000
33,616,000
33,616,00043,585,00044,440,00030,972,00026,941,00050,833,00046,920,00043,048,00026,844,00022,169,00023,508,00022,237,00019,039,00019,598,00019,176,00021,131,00016,859,00015,421,00015,701,00016,936,00011,781,00016,240,00015,620,00015,457,00011,992,00016,258,00019,490,00019,636,00020,293,00014,697,00017,278,00015,204,00011,795,00012,473,00011,183,0009,813,0009,379,00010,425,00011,683,00012,445,00012,669,0007,904,0006,203,0006,008,00014,666,00011,789,00010,347,00013,126,00012,633,00011,824,0009,105,00016,545,00012,425,00012,780,0009,056,00018,051,00016,861,00010,883,0009,708,00011,452,000
   > Long-term Assets 
130,890,000
128,839,000
127,568,000
129,247,000
127,239,000
123,775,000
122,083,000
121,479,000
117,771,000
117,255,000
116,695,000
114,053,000
111,388,000
111,340,000
111,102,000
112,020,000
192,548,000
190,792,000
192,900,000
192,977,000
192,600,000
192,749,000
195,188,000
200,635,000
200,876,000
200,935,000
204,918,000
219,628,000
225,626,000
226,965,000
226,974,000
227,525,000
236,052,000
243,244,000
246,293,000
253,333,000
248,627,000
250,423,000
269,872,000
319,455,000
333,353,000
352,374,000
357,297,000
359,235,000
382,353,000
376,531,000
393,777,000
400,592,000
403,656,000
418,644,000
439,769,000
475,033,000
493,300,000
499,081,000
516,251,000
533,221,000
544,986,000
558,769,000
560,670,000
566,121,000
566,121,000560,670,000558,769,000544,986,000533,221,000516,251,000499,081,000493,300,000475,033,000439,769,000418,644,000403,656,000400,592,000393,777,000376,531,000382,353,000359,235,000357,297,000352,374,000333,353,000319,455,000269,872,000250,423,000248,627,000253,333,000246,293,000243,244,000236,052,000227,525,000226,974,000226,965,000225,626,000219,628,000204,918,000200,935,000200,876,000200,635,000195,188,000192,749,000192,600,000192,977,000192,900,000190,792,000192,548,000112,020,000111,102,000111,340,000111,388,000114,053,000116,695,000117,255,000117,771,000121,479,000122,083,000123,775,000127,239,000129,247,000127,568,000128,839,000130,890,000
       Property Plant Equipment 
97,052,000
96,223,000
93,674,000
93,662,000
91,381,000
89,761,000
88,445,000
87,953,000
86,119,000
83,533,000
81,773,000
82,933,000
80,949,000
81,865,000
82,172,000
82,272,000
141,283,000
139,902,000
138,437,000
140,445,000
139,437,000
139,953,000
139,079,000
140,245,000
140,672,000
141,932,000
142,809,000
153,545,000
159,444,000
157,618,000
156,388,000
157,081,000
163,319,000
171,309,000
170,475,000
171,569,000
174,648,000
179,154,000
187,605,000
222,388,000
234,525,000
255,350,000
258,323,000
265,308,000
285,822,000
282,939,000
297,209,000
297,490,000
298,814,000
316,873,000
333,197,000
352,107,000
361,131,000
366,910,000
373,217,000
386,651,000
399,777,000
405,765,000
417,833,000
420,701,000
420,701,000417,833,000405,765,000399,777,000386,651,000373,217,000366,910,000361,131,000352,107,000333,197,000316,873,000298,814,000297,490,000297,209,000282,939,000285,822,000265,308,000258,323,000255,350,000234,525,000222,388,000187,605,000179,154,000174,648,000171,569,000170,475,000171,309,000163,319,000157,081,000156,388,000157,618,000159,444,000153,545,000142,809,000141,932,000140,672,000140,245,000139,079,000139,953,000139,437,000140,445,000138,437,000139,902,000141,283,00082,272,00082,172,00081,865,00080,949,00082,933,00081,773,00083,533,00086,119,00087,953,00088,445,00089,761,00091,381,00093,662,00093,674,00096,223,00097,052,000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,740,000
24,315,000
24,081,000
26,186,000
24,848,000
24,514,000
7,769,593
38,799,000
42,438,000
40,738,000
38,145,000
2,958,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,958,00038,145,00040,738,00042,438,00038,799,0007,769,59324,514,00024,848,00026,186,00024,081,00024,315,00023,740,00000000000000000000000000000000000
       Intangible Assets 
3,227,000
2,967,000
2,722,000
3,243,000
2,956,000
2,633,000
2,561,000
2,362,000
2,338,000
2,378,000
2,133,000
0
1,913,000
1,729,000
1,673,000
1,702,000
6,647,000
7,162,000
8,386,000
9,514,000
9,388,000
9,588,000
0
11,286,000
11,815,000
10,852,000
13,310,000
13,511,000
13,754,000
16,591,000
17,304,000
19,299,000
20,262,000
19,640,000
21,207,000
21,078,000
17,853,000
18,081,000
19,780,000
22,699,000
21,871,000
22,433,000
22,401,000
23,540,000
23,819,000
24,017,000
23,790,000
23,880,000
26,018,000
25,269,000
24,792,000
21,974,000
24,897,000
25,520,000
26,335,000
25,141,000
19,692,000
20,688,000
19,981,000
19,860,000
19,860,00019,981,00020,688,00019,692,00025,141,00026,335,00025,520,00024,897,00021,974,00024,792,00025,269,00026,018,00023,880,00023,790,00024,017,00023,819,00023,540,00022,401,00022,433,00021,871,00022,699,00019,780,00018,081,00017,853,00021,078,00021,207,00019,640,00020,262,00019,299,00017,304,00016,591,00013,754,00013,511,00013,310,00010,852,00011,815,00011,286,00009,588,0009,388,0009,514,0008,386,0007,162,0006,647,0001,702,0001,673,0001,729,0001,913,00002,133,0002,378,0002,338,0002,362,0002,561,0002,633,0002,956,0003,243,0002,722,0002,967,0003,227,000
       Long-term Assets Other 
52,441,000
61,701,000
63,550,000
60,249,000
63,748,000
69,771,000
67,054,000
68,337,000
66,637,000
68,201,000
68,448,000
69,691,000
75,851,000
79,866,000
109,865,000
110,016,000
124,982,000
136,163,000
125,061,000
134,281,000
129,991,000
129,347,000
129,110,000
128,706,000
126,736,000
132,828,000
134,074,000
147,251,000
126,790,000
123,339,000
123,316,000
124,141,000
122,571,000
124,438,000
125,257,000
118,853,000
130,439,000
135,721,000
143,786,000
131,610,000
143,436,000
143,482,000
141,297,000
153,866,000
162,578,000
121,947,000
163,485,000
194,734,000
210,271,000
231,903,000
232,858,000
246,489,000
242,041,000
273,240,000
317,900,000
335,286,000
61,524,000
58,196,000
52,437,000
61,086,000
61,086,00052,437,00058,196,00061,524,000335,286,000317,900,000273,240,000242,041,000246,489,000232,858,000231,903,000210,271,000194,734,000163,485,000121,947,000162,578,000153,866,000141,297,000143,482,000143,436,000131,610,000143,786,000135,721,000130,439,000118,853,000125,257,000124,438,000122,571,000124,141,000123,316,000123,339,000126,790,000147,251,000134,074,000132,828,000126,736,000128,706,000129,110,000129,347,000129,991,000134,281,000125,061,000136,163,000124,982,000110,016,000109,865,00079,866,00075,851,00069,691,00068,448,00068,201,00066,637,00068,337,00067,054,00069,771,00063,748,00060,249,00063,550,00061,701,00052,441,000
> Total Liabilities 
78,388,000
85,752,000
86,887,000
105,863,000
82,779,000
73,294,000
64,426,000
58,622,000
77,257,000
74,093,000
82,771,000
74,410,000
71,715,000
72,798,000
76,386,000
97,646,000
102,085,000
105,702,000
119,698,000
124,008,000
124,203,000
122,758,000
130,195,000
141,782,000
132,317,000
130,870,000
138,424,000
160,130,000
142,661,000
137,481,000
138,658,000
159,788,000
150,407,000
153,522,000
143,387,000
159,576,000
141,542,000
141,688,000
151,195,000
163,020,000
171,778,000
194,455,000
212,200,000
204,930,000
191,487,000
166,203,000
210,838,000
255,495,000
162,019,000
223,709,000
262,714,000
350,677,000
344,438,000
318,264,000
392,192,000
445,371,000
335,050,000
318,266,000
282,657,000
306,967,000
306,967,000282,657,000318,266,000335,050,000445,371,000392,192,000318,264,000344,438,000350,677,000262,714,000223,709,000162,019,000255,495,000210,838,000166,203,000191,487,000204,930,000212,200,000194,455,000171,778,000163,020,000151,195,000141,688,000141,542,000159,576,000143,387,000153,522,000150,407,000159,788,000138,658,000137,481,000142,661,000160,130,000138,424,000130,870,000132,317,000141,782,000130,195,000122,758,000124,203,000124,008,000119,698,000105,702,000102,085,00097,646,00076,386,00072,798,00071,715,00074,410,00082,771,00074,093,00077,257,00058,622,00064,426,00073,294,00082,779,000105,863,00086,887,00085,752,00078,388,000
   > Total Current Liabilities 
75,390,000
82,492,000
83,282,000
100,482,000
77,592,000
68,465,000
59,432,000
54,580,000
71,953,000
68,782,000
77,330,000
68,822,000
66,203,000
67,311,000
70,598,000
91,633,000
77,321,000
81,632,000
94,263,000
97,667,000
99,257,000
97,513,000
103,532,000
114,350,000
106,296,000
104,302,000
111,682,000
133,058,000
116,021,000
107,881,000
107,703,000
123,660,000
114,565,000
117,437,000
106,197,000
122,902,000
119,858,000
119,811,000
128,352,000
135,218,000
136,523,000
159,588,000
178,271,000
179,268,000
167,207,000
141,824,000
184,678,000
236,070,000
144,103,000
205,910,000
244,669,000
327,422,000
320,515,000
294,442,000
368,966,000
423,730,000
315,151,000
298,465,000
264,124,000
288,217,000
288,217,000264,124,000298,465,000315,151,000423,730,000368,966,000294,442,000320,515,000327,422,000244,669,000205,910,000144,103,000236,070,000184,678,000141,824,000167,207,000179,268,000178,271,000159,588,000136,523,000135,218,000128,352,000119,811,000119,858,000122,902,000106,197,000117,437,000114,565,000123,660,000107,703,000107,881,000116,021,000133,058,000111,682,000104,302,000106,296,000114,350,000103,532,00097,513,00099,257,00097,667,00094,263,00081,632,00077,321,00091,633,00070,598,00067,311,00066,203,00068,822,00077,330,00068,782,00071,953,00054,580,00059,432,00068,465,00077,592,000100,482,00083,282,00082,492,00075,390,000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,000
44,000
41,000
38,000
37,000
38,000
40,000
29,000
22,000
17,000
130,000
131,000
129,000
130,000
132,000
135,000
134,000
132,000
130,000
129,000
134,000
134,000
133,000
133,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,434,000
0
0
0
0
00006,434,000000000000000000133,000133,000134,000134,000129,000130,000132,000134,000135,000132,000130,000129,000131,000130,00017,00022,00029,00040,00038,00037,00038,00041,00044,00044,0000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
611,000
403,000
369,000
336,000
314,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000314,000336,000369,000403,000611,00000000000000000000000000000000000
       Accounts payable 
34,030,000
37,812,000
34,326,000
40,862,000
35,420,000
32,188,000
26,247,000
25,422,000
29,505,000
28,455,000
29,205,000
25,237,000
23,907,000
26,759,000
29,177,000
41,725,000
45,844,000
48,130,000
59,142,000
59,544,000
58,420,000
60,667,000
62,983,000
62,694,000
67,200,000
61,670,000
64,681,000
78,353,000
65,591,000
52,625,000
59,208,000
72,346,000
70,907,000
74,543,000
58,054,000
63,518,000
66,925,000
70,351,000
72,977,000
71,706,000
77,421,000
90,856,000
103,377,000
77,635,000
89,481,000
63,176,000
87,037,000
100,396,000
61,571,000
106,811,000
138,262,000
152,266,000
153,074,000
93,258,000
188,216,000
209,835,000
166,171,000
97,801,000
112,379,000
112,468,000
112,468,000112,379,00097,801,000166,171,000209,835,000188,216,00093,258,000153,074,000152,266,000138,262,000106,811,00061,571,000100,396,00087,037,00063,176,00089,481,00077,635,000103,377,00090,856,00077,421,00071,706,00072,977,00070,351,00066,925,00063,518,00058,054,00074,543,00070,907,00072,346,00059,208,00052,625,00065,591,00078,353,00064,681,00061,670,00067,200,00062,694,00062,983,00060,667,00058,420,00059,544,00059,142,00048,130,00045,844,00041,725,00029,177,00026,759,00023,907,00025,237,00029,205,00028,455,00029,505,00025,422,00026,247,00032,188,00035,420,00040,862,00034,326,00037,812,00034,030,000
       Other Current Liabilities 
41,360,000
44,680,000
48,956,000
59,620,000
42,172,000
36,277,000
33,185,000
29,158,000
42,448,000
40,327,000
48,125,000
43,585,000
42,296,000
40,552,000
41,421,000
49,908,000
24,617,000
20,619,000
25,565,000
25,307,000
27,377,000
23,780,000
29,303,000
34,021,000
31,637,000
31,085,000
39,537,000
41,261,000
44,195,000
43,482,000
43,177,000
40,570,000
36,748,000
33,155,000
39,810,000
40,635,000
40,561,000
33,041,000
40,822,000
43,811,000
59,102,000
68,732,000
74,894,000
101,633,000
77,726,000
78,648,000
97,641,000
135,674,000
82,532,000
99,099,000
106,407,000
175,156,000
167,441,000
201,184,000
180,750,000
207,382,000
148,980,000
200,664,000
151,745,000
175,749,000
175,749,000151,745,000200,664,000148,980,000207,382,000180,750,000201,184,000167,441,000175,156,000106,407,00099,099,00082,532,000135,674,00097,641,00078,648,00077,726,000101,633,00074,894,00068,732,00059,102,00043,811,00040,822,00033,041,00040,561,00040,635,00039,810,00033,155,00036,748,00040,570,00043,177,00043,482,00044,195,00041,261,00039,537,00031,085,00031,637,00034,021,00029,303,00023,780,00027,377,00025,307,00025,565,00020,619,00024,617,00049,908,00041,421,00040,552,00042,296,00043,585,00048,125,00040,327,00042,448,00029,158,00033,185,00036,277,00042,172,00059,620,00048,956,00044,680,00041,360,000
   > Long-term Liabilities 
2,998,000
3,260,000
3,605,000
5,381,000
5,187,000
4,829,000
4,994,000
4,042,000
5,304,000
5,311,000
5,441,000
5,588,000
5,512,000
5,487,000
5,788,000
6,013,000
24,764,000
24,070,000
25,435,000
26,341,000
24,946,000
25,245,000
26,663,000
27,432,000
26,021,000
26,568,000
26,742,000
27,072,000
26,640,000
29,600,000
30,955,000
36,128,000
35,842,000
36,085,000
37,190,000
36,674,000
21,684,000
21,877,000
22,843,000
27,802,000
35,255,000
34,867,000
33,929,000
25,662,000
24,280,000
24,379,000
26,160,000
19,425,000
17,916,000
17,799,000
18,045,000
23,255,000
23,923,000
23,822,000
23,226,000
21,641,000
19,899,000
19,801,000
18,533,000
18,750,000
18,750,00018,533,00019,801,00019,899,00021,641,00023,226,00023,822,00023,923,00023,255,00018,045,00017,799,00017,916,00019,425,00026,160,00024,379,00024,280,00025,662,00033,929,00034,867,00035,255,00027,802,00022,843,00021,877,00021,684,00036,674,00037,190,00036,085,00035,842,00036,128,00030,955,00029,600,00026,640,00027,072,00026,742,00026,568,00026,021,00027,432,00026,663,00025,245,00024,946,00026,341,00025,435,00024,070,00024,764,0006,013,0005,788,0005,487,0005,512,0005,588,0005,441,0005,311,0005,304,0004,042,0004,994,0004,829,0005,187,0005,381,0003,605,0003,260,0002,998,000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,365,000
35,814,000
36,951,000
36,467,000
21,504,000
21,730,000
5,656,654
27,720,000
35,255,000
34,867,000
33,929,000
20,173,000
24,280,000
24,379,000
26,160,000
14,790,000
17,916,000
17,799,000
18,045,000
13,765,000
23,923,000
23,822,000
23,226,000
21,641,000
0
0
0
0
000021,641,00023,226,00023,822,00023,923,00013,765,00018,045,00017,799,00017,916,00014,790,00026,160,00024,379,00024,280,00020,173,00033,929,00034,867,00035,255,00027,720,0005,656,65421,730,00021,504,00036,467,00036,951,00035,814,00035,365,00000000000000000000000000000000000
> Total Stockholder Equity
399,027,000
414,149,000
417,021,000
432,898,000
427,058,000
432,453,000
435,576,000
448,031,000
441,984,000
453,896,000
450,667,000
457,864,000
459,661,000
468,176,000
466,784,000
488,870,000
529,061,000
547,437,000
550,687,000
571,692,000
575,968,000
584,390,000
582,392,000
596,099,000
593,775,000
612,552,000
613,918,000
625,857,000
618,682,000
628,785,000
630,445,000
645,508,000
646,997,000
667,632,000
673,772,000
691,924,000
710,133,000
731,174,000
738,977,000
755,864,000
760,464,000
792,165,000
813,136,000
853,985,000
854,118,000
905,941,000
925,270,000
980,003,000
982,608,000
1,052,058,000
1,090,649,000
1,188,017,000
1,240,510,000
1,307,340,000
1,308,626,000
1,424,387,000
1,436,923,000
1,513,324,000
1,534,992,000
1,625,580,000
1,625,580,0001,534,992,0001,513,324,0001,436,923,0001,424,387,0001,308,626,0001,307,340,0001,240,510,0001,188,017,0001,090,649,0001,052,058,000982,608,000980,003,000925,270,000905,941,000854,118,000853,985,000813,136,000792,165,000760,464,000755,864,000738,977,000731,174,000710,133,000691,924,000673,772,000667,632,000646,997,000645,508,000630,445,000628,785,000618,682,000625,857,000613,918,000612,552,000593,775,000596,099,000582,392,000584,390,000575,968,000571,692,000550,687,000547,437,000529,061,000488,870,000466,784,000468,176,000459,661,000457,864,000450,667,000453,896,000441,984,000448,031,000435,576,000432,453,000427,058,000432,898,000417,021,000414,149,000399,027,000
   Common Stock
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
72,966,000
0
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
0
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,967,000
72,970,000
72,992,000
72,995,000
18,166,546
73,000,000
73,012,000
73,012,000
73,014,000
73,016,000
73,037,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,000
73,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,202,00073,037,00073,016,00073,014,00073,012,00073,012,00073,000,00018,166,54672,995,00072,992,00072,970,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,00072,967,000072,967,00072,967,00072,967,00072,967,00072,967,00072,967,000072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,00072,966,000
   Retained Earnings 
274,398,000
286,937,000
292,258,000
307,984,000
303,320,000
311,837,000
314,262,000
327,642,000
320,115,000
332,213,000
331,371,000
339,476,000
338,037,000
349,560,000
347,621,000
365,964,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
511,696,000
529,295,000
534,540,000
550,974,000
572,922,000
593,706,000
148,929,842
618,091,000
621,940,000
656,247,000
679,872,000
722,076,000
723,343,000
774,102,000
793,140,000
849,093,000
847,188,000
917,914,000
954,605,000
1,054,050,000
1,110,186,000
1,182,564,000
1,187,852,000
1,293,352,000
1,300,732,000
1,383,925,000
1,395,687,000
1,488,738,000
1,488,738,0001,395,687,0001,383,925,0001,300,732,0001,293,352,0001,187,852,0001,182,564,0001,110,186,0001,054,050,000954,605,000917,914,000847,188,000849,093,000793,140,000774,102,000723,343,000722,076,000679,872,000656,247,000621,940,000618,091,000148,929,842593,706,000572,922,000550,974,000534,540,000529,295,000511,696,0000000000000000000365,964,000347,621,000349,560,000338,037,000339,476,000331,371,000332,213,000320,115,000327,642,000314,262,000311,837,000303,320,000307,984,000292,258,000286,937,000274,398,000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
51,663,000
54,246,000
51,797,000
51,948,000
50,772,000
47,650,000
48,348,000
47,423,000
48,903,000
48,717,000
46,330,000
45,422,000
48,658,000
45,650,000
46,197,000
122,906,000
456,094,000
474,470,000
477,720,000
498,725,000
503,001,000
511,423,000
582,392,000
523,132,000
520,808,000
539,585,000
540,951,000
552,890,000
545,715,000
555,818,000
557,478,000
572,541,000
574,030,000
594,665,000
600,805,000
618,954,000
710,133,000
731,174,000
738,977,000
755,864,000
760,464,000
792,165,000
813,136,000
853,985,000
854,118,000
905,941,000
925,270,000
980,003,000
982,608,000
1,052,058,000
1,090,649,000
1,188,017,000
1,240,510,000
1,307,340,000
68,730,000
68,805,000
68,994,000
69,112,000
69,212,000
69,355,000
69,355,00069,212,00069,112,00068,994,00068,805,00068,730,0001,307,340,0001,240,510,0001,188,017,0001,090,649,0001,052,058,000982,608,000980,003,000925,270,000905,941,000854,118,000853,985,000813,136,000792,165,000760,464,000755,864,000738,977,000731,174,000710,133,000618,954,000600,805,000594,665,000574,030,000572,541,000557,478,000555,818,000545,715,000552,890,000540,951,000539,585,000520,808,000523,132,000582,392,000511,423,000503,001,000498,725,000477,720,000474,470,000456,094,000122,906,00046,197,00045,650,00048,658,00045,422,00046,330,00048,717,00048,903,00047,423,00048,348,00047,650,00050,772,00051,948,00051,797,00054,246,00051,663,000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in JPY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,111,367,000
Cost of Revenue-413,306,000
Gross Profit698,061,000698,061,000
 
Operating Income (+$)
Gross Profit698,061,000
Operating Expense-287,448,000
Operating Income410,613,000410,613,000
 
Operating Expense (+$)
Research Development174,868,000
Selling General Administrative112,857,000
Selling And Marketing Expenses-
Operating Expense287,448,000287,725,000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-27,000
Other Finance Cost-3,034,000
Net Interest Income3,007,000
 
Pretax Income (+$)
Operating Income410,613,000
Net Interest Income3,007,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)443,821,000377,405,000
EBIT - interestExpense = 410,586,000
443,821,000
325,499,000
Interest Expense27,000
Earnings Before Interest and Taxes (EBIT)410,613,000443,848,000
Earnings Before Interest and Taxes (EBITDA)442,353,000
 
After tax Income (+$)
Income Before Tax443,821,000
Tax Provision-133,602,000
Net Income From Continuing Ops336,745,000310,219,000
Net Income325,472,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses700,754,000
Total Other Income/Expenses Net33,208,000-3,007,000
 

Technical Analysis of Chugai Pharmaceutical Co Ltd ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chugai Pharmaceutical Co Ltd ADR. The general trend of Chugai Pharmaceutical Co Ltd ADR is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chugai Pharmaceutical Co Ltd ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chugai Pharmaceutical Co Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.87 < 18.07 < 22.61.

The bearish price targets are: 14.95 > 14.10 > 13.85.

Tweet this
Chugai Pharmaceutical Co Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chugai Pharmaceutical Co Ltd ADR. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chugai Pharmaceutical Co Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chugai Pharmaceutical Co Ltd ADR. The current macd is -0.91486692.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chugai Pharmaceutical Co Ltd ADR price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Chugai Pharmaceutical Co Ltd ADR. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Chugai Pharmaceutical Co Ltd ADR price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Chugai Pharmaceutical Co Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartChugai Pharmaceutical Co Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chugai Pharmaceutical Co Ltd ADR. The current adx is 27.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Chugai Pharmaceutical Co Ltd ADR shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Chugai Pharmaceutical Co Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chugai Pharmaceutical Co Ltd ADR. The current sar is 17.12.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Chugai Pharmaceutical Co Ltd ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chugai Pharmaceutical Co Ltd ADR. The current rsi is 25.98. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Chugai Pharmaceutical Co Ltd ADR Daily Relative Strength Index (RSI) ChartChugai Pharmaceutical Co Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chugai Pharmaceutical Co Ltd ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chugai Pharmaceutical Co Ltd ADR price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Chugai Pharmaceutical Co Ltd ADR Daily Stochastic Oscillator ChartChugai Pharmaceutical Co Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chugai Pharmaceutical Co Ltd ADR. The current cci is -122.30665705.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Chugai Pharmaceutical Co Ltd ADR Daily Commodity Channel Index (CCI) ChartChugai Pharmaceutical Co Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chugai Pharmaceutical Co Ltd ADR. The current cmo is -56.43083267.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Chugai Pharmaceutical Co Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartChugai Pharmaceutical Co Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chugai Pharmaceutical Co Ltd ADR. The current willr is -87.38170347.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Chugai Pharmaceutical Co Ltd ADR Daily Williams %R ChartChugai Pharmaceutical Co Ltd ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chugai Pharmaceutical Co Ltd ADR.

Chugai Pharmaceutical Co Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chugai Pharmaceutical Co Ltd ADR. The current atr is 0.78749889.

Chugai Pharmaceutical Co Ltd ADR Daily Average True Range (ATR) ChartChugai Pharmaceutical Co Ltd ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chugai Pharmaceutical Co Ltd ADR. The current obv is -4,056,471.

Chugai Pharmaceutical Co Ltd ADR Daily On-Balance Volume (OBV) ChartChugai Pharmaceutical Co Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chugai Pharmaceutical Co Ltd ADR. The current mfi is 14.35.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Chugai Pharmaceutical Co Ltd ADR Daily Money Flow Index (MFI) ChartChugai Pharmaceutical Co Ltd ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chugai Pharmaceutical Co Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Chugai Pharmaceutical Co Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chugai Pharmaceutical Co Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.977
Ma 20Greater thanMa 5017.978
Ma 50Greater thanMa 10019.153
Ma 100Greater thanMa 20018.816
OpenGreater thanClose15.940
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chugai Pharmaceutical Co Ltd ADR with someone you think should read this too:
  • Are you bullish or bearish on Chugai Pharmaceutical Co Ltd ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chugai Pharmaceutical Co Ltd ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chugai Pharmaceutical Co Ltd ADR

I send you an email if I find something interesting about Chugai Pharmaceutical Co Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Chugai Pharmaceutical Co Ltd ADR.

Receive notifications about Chugai Pharmaceutical Co Ltd ADR in your mailbox!